ClinicalTrials.Veeva

Menu

Fermented Iron-rich Supplement in Reducing Anemia (FISRA)

U

University of Ghana

Status and phase

Unknown
Phase 2

Conditions

Iron Deficiency Anemia

Treatments

Dietary Supplement: supplement containing 10 mg iron sulfate
Dietary Supplement: iron rich food supplement (10 mg iron)
Dietary Supplement: iron rich food supplement (60 mg iron)
Dietary Supplement: supplement containing 60 mg iron sulfate

Study type

Interventional

Funder types

Other

Identifiers

NCT02037724
UG-0001-IDA

Details and patient eligibility

About

The consequences of iron deficiency anemia in women are enormous, and especially in developing countries, as the condition adversely affects both their productive and reproductive capabilities. The study seeks to: 1) compare changes in iron status indicators among women receiving an iron-rich organic food supplement versus ferrous sulfate supplement, and 2) determine the suitable level of food supplement needed to prevent/reduce iron deficiency anemia among women in developing country settings.

A double-blind, randomized, controlled, intervention trial will be implemented in women of childbearing age, 60 women with iron deficiency anemia and 60 women with iron deficiency. After screening potential subjects (up to 500 expected), approximately 30 will be recruited into each of four study groups; assuming 30% dropout rate, to detect an increase of 30% in ferritin as significant between the two time points at 80% power and alpha value of 0.05. Subjects who meet the inclusion criteria will be randomized into the four groups consisting of: 2 control groups (daily 60mg ferrous sulfate (FS-60) or daily 10mg ferrous sulfate (FS-10)), and 2 test groups (daily 60mg iron-rich supplement (IRS-60) or 10mg iron-rich supplement (IRS-10)). Subjects will take daily FS-60 and IRS-60 under supervision for 8 weeks while subjects taking FS-10 and IRS-10 will take the supplement under supervision for 12 consecutive weeks.

Full description

The design will involve screening of about 500 female adult students and staff of the University of Ghana who meet initial the inclusion criteria. Screening will involve pregnancy testing, assessment of hemoglobin, and ferritin and also administration of a health history questionnaire.

Thereafter, 120 eligible subjects will enrolled and randomized to recieve the treatment. All subjects will complete 3-day dietary record (including 2 weekdays and 1 weekend) at baseline and at endline (i.e. one week prior to treatment completion). The dietary data will be analyzed using nationally-generated food composition tables together with the ESHA food processor software. In addition, body weight and height will be measured using standard methods at baseline and end of the study. Weekly monitoring of side effects will be recorded. Fasting blood samples will be collected at baseline and endline to enable determination of anemia status and other indicators including serum ferritin, transferrin receptor and full blood count, together with C-reactive protein.

Enrollment

120 estimated patients

Sex

Female

Ages

18 to 49 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18-49 years
  • Regular menstruation in the last three months
  • Hemoglobin <12 mg/dl;
  • Serum Ferittin<20mcg/L
  • BMI 18.5Kg/m^2 to 29.9 kg/m^2

Exclusion criteria

  • history of gastrointestinal or hematological disorders,
  • taking medications that could interfere with hematopoiesis or dietary iron absorption
  • pregnant (based on pregnancy test).

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

120 participants in 4 patient groups

supplement containing 60 mg iron sulfate
Other group
Description:
nutrient supplement containing 60 mg of iron as ferous sulfate
Treatment:
Dietary Supplement: supplement containing 10 mg iron sulfate
Dietary Supplement: iron rich food supplement (60 mg iron)
Dietary Supplement: iron rich food supplement (10 mg iron)
iron rich food supplement (60 mg iron)
Experimental group
Description:
contains 60 mg Iron
Treatment:
Dietary Supplement: supplement containing 10 mg iron sulfate
Dietary Supplement: supplement containing 60 mg iron sulfate
Dietary Supplement: iron rich food supplement (10 mg iron)
iron rich food supplement (10 mg iron)
Experimental group
Description:
contains 10 mg of iron
Treatment:
Dietary Supplement: supplement containing 10 mg iron sulfate
Dietary Supplement: iron rich food supplement (60 mg iron)
Dietary Supplement: supplement containing 60 mg iron sulfate
supplement containing 10 mg iron sulfate
Other group
Description:
nutrient supplement containing 10 mg of iron as ferous sulfate
Treatment:
Dietary Supplement: iron rich food supplement (60 mg iron)
Dietary Supplement: supplement containing 60 mg iron sulfate
Dietary Supplement: iron rich food supplement (10 mg iron)

Trial contacts and locations

0

Loading...

Central trial contact

Richmond Aryeetey, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems